Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 1 , Pages 3-9, January 2010

Intranasal Administration of PEGylated Transforming Growth Factor-α Improves Behavioral Deficits in a Chronic Stroke Model

  • Magda Guerra-Crespo, PhD

      Affiliations

    • Department of Anatomy and Neurobiology, University of California Irvine, Irvine, California
    • Corresponding Author InformationAddress correspondence to Dr Magda Guerra-Crespo, University of California Irvine, Department of Anatomy and Neurobiology, 335 Med-Surg II, Irvine, CA92697.
    • ,
  • Andres Sistos, BS

      Affiliations

    • Department of Anatomy and Neurobiology, University of California Irvine, Irvine, California
    • ,
  • Darius Gleason, BS

      Affiliations

    • Department of Developmental and Cell Biology, University of California Irvine, Irvine, California
    • ,
  • James H. Fallon, PhD

      Affiliations

    • Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, California

Received 8 July 2009; received in revised form 2 September 2009; accepted 10 September 2009.

We previously demonstrated that infusion of transforming growth factor (TGF)-α after chronic middle cerebral artery occlusion (MCAO) stimulates stem and progenitor cell proliferation, migration, and neuronal differentiation associated with the amelioration of neurologic impairment. But the use of TGF-α in humans is impeded by impracticality of intracranial infusion and the inability of intravenous TGF-α to cross the blood-brain barrier. Here we investigated whether intranasal delivery of PEGylated TGF-α (PEG-TGF-α) is a viable alternative. We found that intranasal PEG-TGF-α can also induce the proliferation of neural progenitors and their migration to the damaged striatum, and that this is associated with significant behavioral improvement in the MCAO model. This nonsurgical approach represents a potential therapeutic strategy for human patients.

Key Words: Adult stem cell, injury, proliferation, intranasal, neurotrophic factor, PEGylation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1052-3057(09)00194-3

doi:10.1016/j.jstrokecerebrovasdis.2009.09.005

Journal of Stroke & Cerebrovascular Diseases
Volume 19, Issue 1 , Pages 3-9, January 2010

Article Tools

* Image Usage & Resolution